Paper
0
Second Line Treatment in Patients with Multiple Myeloma Progressing after Bortezomib, Lenalidomide, Dexamethasone Induction, Autologous Transplant and Lenalidomide Maintenance
Authors
Oren Pasvolsky,Denái Milton
Mark Tanner,Qaiser Bashir,Samer Srour,Neeraj Saini,Paul Lin,Umar Siddiqui,Hina Khan,Jeremy Ramdial,Yago Nieto,Guilin Tang,Kiran Lakhani,Yosra Aljawai,Partow Kebriaei,Hans Lee,Krina Patel,Sheeba Thomas,Robert Orlowski,Elizabeth Shpall,Richard Champlin
+19 authors
,Muzaffar QazilbashJournal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave